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As HIV-infected patients live longer they are experien-
cing diseases normally associated with ageing, some-
times at higher frequency and at younger ages than
expected. Low bone mineral density (BMD) and osteo-
porosis is one example. Rates of low BMD are high in
HIV-infected patients and fracture rates occur more
commonly and at a younger age than the general popu-
lation. Factors thought to contribute to low BMD in
HIV include HIV infection itself, exposure to antiretro-
viral therapy (ART) and over-representation of tradi-
tional risk factors (such as smoking, hypogonadism and
low body mass index) for low BMD in HIV-infected
populations. Current evidence suggests that patients lose
BMD after ART initiation and, to some extent, with
switch in ART. Rates of BMD loss appear higher when
protease inhibitors or some NRTI are used as part of
the initial ART regimen. This presentation will outline
current data on low BMD in HIV, discuss ways of moni-
toring for low BMD and current approaches to manage-
ment of this common condition.
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